v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   125,794      
Beginning balance at Dec. 31, 2023 $ (220,644) $ 1,259 $ 6,811,063 $ (23,375) $ (7,009,591)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options, net of tax withholdings (in shares)   223      
Exercise of common stock options, net of tax withholdings 24,765 $ 2 24,763    
Issuance of common stock under equity plans (in shares)   446      
Issuance of common stock under equity plans 0 $ 4 (4)    
Stock-based compensation expense 46,155   46,155    
Other comprehensive loss (3,613)     (3,613)  
Net loss (65,935)       (65,935)
Ending balance (in shares) at Mar. 31, 2024   126,463      
Ending balance at Mar. 31, 2024 $ (219,272) $ 1,265 6,881,977 (26,988) (7,075,526)
Beginning balance (in shares) at Dec. 31, 2024 129,294 129,294      
Beginning balance at Dec. 31, 2024 $ 67,088 $ 1,293 7,388,061 (34,518) (7,287,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options, net of tax withholdings (in shares)   423      
Exercise of common stock options, net of tax withholdings 50,985 $ 4 50,981    
Issuance of common stock under equity plans (in shares)   594      
Issuance of common stock under equity plans 0 $ 6 (6)    
Stock-based compensation expense 57,840   57,840    
Other comprehensive loss (2,999)     (2,999)  
Net loss $ (57,479)       (57,479)
Ending balance (in shares) at Mar. 31, 2025 130,311 130,311      
Ending balance at Mar. 31, 2025 $ 115,435 $ 1,303 $ 7,496,876 $ (37,517) $ (7,345,227)